In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)
By Ahmed El-Medany One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For…
View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)
In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)
One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For those that were unable to attend, or for the sake of refreshing one’s memory, the following is a summary of all the trials presented…
View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)
Novel pacing system improves clinical response in heart failure patients un-responsive to, or unsuitable for, cardiac resynchronisation therapy
overall, the results looked great. Hopefully, over the course of the next 12 months, we will finish recruitment for the final phase of the study to further confirm the primary safety and efficacy endpoints that we saw with the….
View More Novel pacing system improves clinical response in heart failure patients un-responsive to, or unsuitable for, cardiac resynchronisation therapy
Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial
‘These findings provide clinicians with evidence to embrace moderate-intensity aerobic exercise as a standard coadjutant therapy targeting this patient population.’ The authors state.
View More Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial
FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway
By Elisabeth Mahase Taken Directly from the BMJ doi: https://doi.org/10.1136/bmj.n1898 Criticisms of the US Food and Drug Administration’s accelerated approval process have resurfaced after the recent…
View More FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway
Impact of adiposity on cardiovascular outcomes: an umbrella review and meta-analysis provides updated insights
The aim of this study was to investigate the causal relationship and evidence of an association between increased adiposity and the risk of incident cardiovascular disease (CVD) events or mortality.
View More Impact of adiposity on cardiovascular outcomes: an umbrella review and meta-analysis provides updated insights
Anticoagulation of Patients with Mechanical Heart Valves.
The British Cardiovascular Society (BCS) has today released a Joint Statement together with the British Heart Valve Society (BHVS), the Society for Cardiothoracic Surgeons (SCTS),…
View More Anticoagulation of Patients with Mechanical Heart Valves.
Clinical outcome of COVID-19 in patients with adult congenital heart disease
By Saadia Aslam Original research from Professor Markus Schwerzmann and his team collected clinical outcome data to help identify risk factors for a complicated course…
View More Clinical outcome of COVID-19 in patients with adult congenital heart disease
Heart failure with preserved ejection fraction
By Sean Zheng Key messages Heart failure with preserved ejection fraction (HFPEF) is a common cause of hospitalisation, impaired quality of life, restricted functional capacity,…
View More Heart failure with preserved ejection fraction
Utility of CT coronary angiography in non-ST elevation acute coronary syndrome
By Syed Ghias Take Home Messages Coronary computed tomographic angiography (CCTA) is a well-established non-invasive diagnostic modality which reliably rules out obstructive coronary artery disease…
View More Utility of CT coronary angiography in non-ST elevation acute coronary syndrome